Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Gunes Dinc"'
Autor:
Abhishek K Srivastava, Rajesh K Sharma, Esma S Yolcu, Vahap Ulker, Kathryn MacLeod, Gunes Dinc, Haval Shirwan
Publikováno v:
PLoS ONE, Vol 7, Iss 11, p e48463 (2012)
Subunit vaccines containing universal tumor associated antigens (TAAs) present an attractive treatment modality for cancer primarily due to their safety and potential to generate long-term immunological responses that can safeguard against recurrence
Externí odkaz:
https://doaj.org/article/ada9d8891aa4404995a7a5b010953096
Autor:
Haval Shirwan, Hong Zhao, Esma S. Yolcu, Rajesh K. Sharma, Gunes Dinc, Abhishek K. Srivastava
Supplemental Figures S1-4, Tables S1-2, Methods and Materials. Figure S1. Tumor growth kinetics of individual mice subjected to various vaccinations. Figure S2. Absolute number of E749-57 peptide-specific CD8+ T cells expressing polyfunctional cytoki
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e88db32516e04e75a54863718fabcf1
https://doi.org/10.1158/0008-5472.22403016.v1
https://doi.org/10.1158/0008-5472.22403016.v1
Autor:
Nergiz Bengu, Zerrin Ataman, Seyda Seren Intepeler, Hasan Fehmi Dirik, Serap Ileri, Nuray Gunes Dinc, Gülay Esrefgil, Fatma Yilmazmis
Publikováno v:
Contemporary Nurse. 55:380-390
Background: Nursing shortage is a major global concern about healthcare. In this regard, nurses? organizational commitment is an important issue that should be focused on. Since limited data are available about the factors associated with nurse organ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66ac2221a7aec3af4e15dd79ccee36e7
https://doi.org/10.1080/10376178.2019.1673668
https://doi.org/10.1080/10376178.2019.1673668
Publikováno v:
Vaccine. 32:5035-5040
The lead candidate plague subunit vaccine is the recombinant fusion protein rF1-V adjuvanted with alum. While alum generates Th 2 regulated robust humoral responses, immune protection against Yersinia pestis has been shown to also involve Th 1 driven
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0bdd945106c988e0002949460381662
https://doi.org/10.1016/j.vaccine.2014.07.015
https://doi.org/10.1016/j.vaccine.2014.07.015
Autor:
Seren Intepeler, Seyda, Esrefgil, Gülay, Yilmazmis, Fatma, Bengu, Nergiz, Gunes Dinc, Nuray, Ileri, Serap, Ataman, Zerrin, Dirik, Hasan Fehmi
Publikováno v:
Contemporary Nurse: A Journal for the Australian Nursing Profession; Aug-Oct2019, Vol. 55 Issue 4/5, p380-390, 11p, 3 Charts
Autor:
Abhishek K. Srivastava, Hong Zhao, Gunes Dinc, Rajesh K. Sharma, Esma S. Yolcu, Haval Shirwan
Vaccines based on tumor-associated antigens (TAA) have limited therapeutic efficacy due to their weak immunogenic nature and the various immune evasion mechanisms active in advanced tumors. In an effort to overcome these limitations, we evaluated a c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81db4af071544c9d51315dbea46489c6
https://europepmc.org/articles/PMC4233189/
https://europepmc.org/articles/PMC4233189/
Publikováno v:
OncoImmunology. 5:e1064580
Practical experience with cancer vaccines combined with accumulated knowledge of the complex interactions between cancer and immune system rationalize the combinatorial use of immune adjuvants for better efficacy. We recently described a novel adjuva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c34bd7b594ad3877f7e927ca1cecfb7b
https://doi.org/10.1080/2162402x.2015.1064580
https://doi.org/10.1080/2162402x.2015.1064580
Publikováno v:
The Journal of Immunology. 190:45.15-45.15
Although subunit cancer vaccines based on tumor associated antigens (TAAs) are attractive as treatment modalities, they have limited therapeutic efficacy due to their weak immunogenicity and tumor immune evasion mechanisms. Adjuvants with potent immu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c074aec089949e331c97bdf85123f92a
https://doi.org/10.4049/jimmunol.190.supp.45.15
https://doi.org/10.4049/jimmunol.190.supp.45.15
Autor:
Esma S. Yolcu, Haval Shirwan, Vahap Ulker, Abhishek K. Srivastava, Gunes Dinc, Rajesh K. Sharma, Kathryn J. MacLeod
Publikováno v:
PLoS ONE
PLoS ONE, Vol 7, Iss 11, p e48463 (2012)
PLoS ONE, Vol 7, Iss 11, p e48463 (2012)
Subunit vaccines containing universal tumor associated antigens (TAAs) present an attractive treatment modality for cancer primarily due to their safety and potential to generate long-term immunological responses that can safeguard against recurrence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca0060ad0ece774c37fb1217fec90eae
https://doi.org/10.1371/journal.pone.0048463
https://doi.org/10.1371/journal.pone.0048463